Gail Rodgers > DLA Piper LLP (US) > New York, United States > Lawyer Profile
DLA Piper LLP (US) Offices
1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States
- Firm Profile
- Go to...
Gail Rodgers
Work Department
Litigation, Arbitration and Investigations; Class Actions; Product Liability, Mass Torts and Product Stewardship; White Collar and Corporate Crime; Healthcare; Life Sciences
Position
Partner
Career
Gail Rodgers is a partner in DLA Piper’s global Litigation practice. She is based in New York and concentrates her practice on investigations and compliance.
Gail Rodgers has spent the majority of her career representing multinational pharmaceutical and medical device companies. Gail focuses her practice on end to end compliance and investigations including regarding bribery and corruption. She has represented multiple Fortune 500 companies in cross border and multi-jurisdictional investigations involving allegations of violations of the Foreign Corrupt Practices Act and the UK Bribery Act. She has extensive experience leading teams for corporate internal and government investigations across the globe.
Gail also conducts proactive global compliance reviews and partners with the business in implementing controls and remediations and evaluating the efficacy of compliance and investigations programs and protocols. A significant portion of her practice involves providing clients with strategic business advice.
Ms. Rodgers has extensive experience in a wide variety of state and federal litigation, and has focused on pharmaceutical and medical device litigation, including providing strategic advice at each stage of a litigation, managing national discovery teams, depositions, motions practice including Daubert challenges and implementation of national resolution programs. She has represented several of the largest pharmaceutical companies in the world.
Before her legal career, Ms. Rodgers practiced as a Registered Nurse in the Critical Care Units of MD Anderson Cancer Center. Her medical experience provides her and her clients a distinct advantage, as it gives Ms. Rodgers particular insight into complex medical issues, scientific evidence, expert development, depositions of medical fact witnesses and case valuation.
Ms. Rodgers also has significant experience as resolution counsel and has coordinated a team of medical specialists in the evaluation of individual and class action claims, resulting in the resolution of thousands of claims.
Ms. Rodgers handled over a hundred medical malpractice actions against a bankrupt hospital, negotiating dozens of multi-million dollar claims resulting in settlements for a fraction of the amounts claimed or outright dismissals of the claims.
Ms. Rodgers is passionate about pro bono work and has represented asylum applicants almost the entirety of her career. All of her clients have been successful in their quest to remain in the United States. She mentors multiple teams of junior associates, typically managing seven or eight cases at a time. She also has represented prisoners in compassionate release cases.
Ms. Rodgers is equally as passionate about diversity, equity and inclusion as it is a cornerstone of her personal life. She enjoys mentoring and sponsoring junior attorneys, particularly those who are diverse. During her decade in leadership of the DRI Drug and Medical Device Committee, she has purposefully and significantly increased the percentage of diverse and women attorneys in leadership as well as the speakers at the DRI Drug and Medical Device Seminar. She also has actively encouraged young and diverse attorneys to engage with the Committee and work towards leadership roles.
Memberships
Food and Drug Law Institute (FDLI); American Constitution Society; Defense Research Institute (DRI); International Association of Defense Counsel
Education
J.D., University of Houston Law Center; B.S.N., University of Texas; R.N., Baptist Hospital School of Nursing
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Industry focus > Cannabis
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Intellectual property > Copyright
- Environment > Environment: regulatory
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Dispute resolution > Corporate investigations and white-collar criminal defense